Menta Capital’s NxStage Medical Inc. NXTM Stock Holding History

Menta Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,545	Closed	-$216K	–	685
2018 Q4	$216K	Sell	7,545 -8,836	-54%	-$251K	0.08%	408
2018 Q3	$457K	Buy	+16,381	New	+$461K	0.16%	243
2018 Q2	–	Sell	-52,559	Closed	-$1.31M	–	820
2018 Q1	$1.31M	Buy	+52,559	New	+$1.28M	0.28%	105
2017 Q4	–	Sell	-9,960	Closed	-$275K	–	891
2017 Q3	$275K	Sell	9,960 -15,440	-61%	-$412K	0.04%	643
2017 Q2	$637K	Buy	25,400 +17,502	+222%	+$433K	0.08%	458
2017 Q1	$212K	Buy	+7,898	New	+$218K	0.02%	746
2016 Q3	–	Sell	-37,180	Closed	-$806K	–	1037
2016 Q2	$806K	Buy	37,180 +380	+1%	+$6.78K	0.11%	323
2016 Q1	$552K	Buy	+36,800	New	+$617K	0.08%	452

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Menta Capital's NXTM Position: Q1 2019 in Review

Menta Capital sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 7,545 shares — an estimated $216K sold.

Menta Capital first reported a position in NXTM in Q1 2016 and held it in 8 quarters. The position peaked at $1.31M in Q1 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Menta Capital reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Menta Capital sold 7,545 NxStage Medical Inc. shares in Q1 2019, an estimated $216K.
Menta Capital first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 8 quarters.
Menta Capital's NxStage Medical Inc. position peaked at $1.31M in Q1 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Menta Capital's 13F filing for Q1 2019, filed 1 May 2019.